EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI Germany GmbH
02 1Dr.Reddy's Laboratoriees Limited
03 1Aarti Pharmalabs Limited
04 1Neuland Laboratories Limited
05 1Aurobindo Pharma Limited
06 1Cipla Ltd.
07 1Hetero Labs Limited
08 1Honour Lab Limited
09 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 9Ramipril
01 1China
02 1France
03 7India
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
NDC Package Code : 82348-101
Start Marketing Date : 2010-07-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-057
Start Marketing Date : 2002-10-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0300
Start Marketing Date : 2016-08-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-0123
Start Marketing Date : 2017-12-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-320
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7573
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0004
Start Marketing Date : 1991-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0051
Start Marketing Date : 1991-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-118
Start Marketing Date : 2008-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ramipril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ramipril, including repackagers and relabelers. The FDA regulates Ramipril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ramipril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ramipril manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ramipril supplier is an individual or a company that provides Ramipril active pharmaceutical ingredient (API) or Ramipril finished formulations upon request. The Ramipril suppliers may include Ramipril API manufacturers, exporters, distributors and traders.
click here to find a list of Ramipril suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ramipril as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ramipril API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ramipril as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ramipril and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ramipril NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ramipril suppliers with NDC on PharmaCompass.
We have 9 companies offering Ramipril
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
